Dihydroartemisinin + Piperaquine tetraphosphate + TAFENOQUINE for malaria, vivax

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Jul 2014: Trial registered, NCT02184637
  2. 31 Jul 2014: Trial started, NCT02184637

The trials

NCT02184637: A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

State
Completed
Phase
Phase 1
People
120 taking part
Started
31 Jul 2014
Primary completion
8 Apr 2015
Arms
Cohort 1- TQ w/DHA+PQP
Results
None posted
Papers
doi:10.1128/aac.01588-16
  1. 9 Jul 2014: Trial registered
  2. 31 Jul 2014: Trial started
  3. 8 Apr 2015: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.